Oxaliplatin and Hepatitis b - a phase IV clinical study of FDA data
Summary:
Hepatitis b is reported as a side effect among people who take Oxaliplatin (oxaliplatin), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fluorouracil, and have Hepatic cancer metastatic.
The phase IV clinical study analyzes which people have Hepatitis b when taking Oxaliplatin. It is created by eHealthMe based on reports of 71,972 people who have side effects when taking Oxaliplatin from the FDA, and is updated regularly.
What is Oxaliplatin?
Oxaliplatin has active ingredients of oxaliplatin. It is often used in colon cancer. eHealthMe is studying from 72,058 Oxaliplatin users. Check the latest studies of Oxaliplatin.
What is Hepatitis b?
Hepatitis b is found to be associated with 519 drugs and 679 conditions by eHealthMe. Check the latest studies of Hepatitis b.
71,972 people reported to have side effects when taking Oxaliplatin.
Among them, 49 people (0.07%) have Hepatitis b.

Among these 49 people:
How long have people been on Oxaliplatin when they have Hepatitis b? *
- < 1 month: 55.56 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 11.11 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hepatitis b when taking Oxaliplatin? *
- female: 17.07 %
- male: 82.93 %
What is the age of people who have Hepatitis b when taking Oxaliplatin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 16.22 %
- 50-59: 27.03 %
- 60+: 56.76 %
What are other drugs people take besides Oxaliplatin? *
- Fluorouracil: 10 people, 20.41%
- Cyclophosphamide: 6 people, 12.24%
- Ifosfamide: 4 people, 8.16%
- Carboplatin: 4 people, 8.16%
- Prednisolone: 4 people, 8.16%
- Doxorubicin Hydrochloride: 4 people, 8.16%
- Etoposide: 4 people, 8.16%
- Mesna: 4 people, 8.16%
- Sorafenib: 4 people, 8.16%
- Gemcitabine Hydrochloride: 3 people, 6.12%
What are other side effects people have besides Hepatitis b? *
- Hepatic Failure (liver failure): 8 people, 16.33%
- Disease Progression: 7 people, 14.29%
- Drug Ineffective: 5 people, 10.20%
- Pleural Effusion (water on the lungs): 4 people, 8.16%
- Febrile Neutropenia (fever with reduced white blood cells): 4 people, 8.16%
- Blood Lactate Dehydrogenase Increased: 4 people, 8.16%
- Malignant Neoplasm Progression (cancer tumour came back): 4 people, 8.16%
- Mucosal Inflammation (infection of mucous membrane): 4 people, 8.16%
- Neuropathy Peripheral (surface nerve damage): 4 people, 8.16%
- Pelvic Pain: 4 people, 8.16%
What are the existing conditions these people have? *
- Hepatic Cancer Metastatic (liver cancer - metastatic): 9 people, 18.37%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 14.29%
- Colorectal Cancer Stage Iii (colon and rectal cancer spreads to lymph nodes): 4 people, 8.16%
- Rectal Cancer Metastatic (cancer of rectum spreads to other): 3 people, 6.12%
- Rectal Cancer (cancer of rectum): 3 people, 6.12%
- Metastases To Lung (cancer spreads to lung): 3 people, 6.12%
- Breast Cancer: 2 people, 4.08%
- Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 2 people, 4.08%
- Glioma (a type of tumour that starts in the brain or spine): 1 person, 2.04%
- Hepatocellular Carcinoma (liver cancer): 1 person, 2.04%
* Approximation only. Some reports may have incomplete information.
Do you take Oxaliplatin and have Hepatitis b?
- Check whether Hepatitis b is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Oxaliplatin:
- Oxaliplatin (72,058 reports)
Hepatitis b treatments and more:
- Hepatitis b (21,088 reports)
How severe was Hepatitis b and when was it recovered:
Expand to all the drugs that have ingredients of oxaliplatin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Oxaliplatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hepatitis b:
- Hepatitis b (519 drugs)
Browse all the conditions that are associated with Hepatitis b:
- Hepatitis b (679 conditions)
Related publications that referenced our studies
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
- Kim HJ, An SH, Cho YH, Kim SY, Lee HG, Yoon SY, "Oxaliplatin-induced Torsades de pointes and long QT syndrome in a patient with gastric cancer", Acta Oncologica, 2013 Aug .
- Wang JH, King TM, Chang MC, Hsu CW, "Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis", World journal of gastroenterology: WJG, 2012 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on oxaliplatin (the active ingredients of Oxaliplatin) and Oxaliplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flunisolide vs. Allegra, side effect and effectiveness comparison - 10 seconds ago
- Could Omeprazole cause Eye Movements - Uncontrollable? - 11 seconds ago
- Could Paracetamol cause Gallbladder Disorder? - 15 seconds ago
- Could Ofloxacin cause Drug Rash With Eosinophilia And Systemic Symptoms? - 29 seconds ago
- Cardiac Disorder and Drug Level Decreased - 32 seconds ago
- Drug interactions of Covera-Hs and Gentamicin - 38 seconds ago
- Cymbalta vs. Silenor, side effect and effectiveness comparison - 48 seconds ago
- Could Darvocet cause Restless Leg Syndrome? - 52 seconds ago
- Amoxicillin vs. Augmentin '875', side effect and effectiveness comparison - a minute ago
- Could Promethazine cause Barrett'S Oesophagus? - a minute ago